No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis

AIM: Hepatitis C virus (HCV) is the leading cause of hepatocellular carcinoma (HCC) in the United States. Achieving sustained viral response with interferon (IFN) treatment reduces the risk from 3%-5% to 0.5%-1% annually. Several studies reported unexpectedly high rates of HCC after treatment with d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutledge, Stephanie M., Zheng, Hui, Li, Darrick K., Chung, Raymond T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709867/
https://www.ncbi.nlm.nih.gov/pubmed/31453368
http://dx.doi.org/10.20517/2394-5079.2019.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709867/
https://www.ncbi.nlm.nih.gov/pubmed/31453368
http://dx.doi.org/10.20517/2394-5079.2019.19

Ejemplares similares